Defining Your Appropriate Evaluation Measures There is no one “right” evaluation. Rather, a host of evaluation questions may arise over the life of a program that might reasonably be asked at any point in time. Addressing these questions about program effectiveness means paying attention … Read More
The Importance of Strong Program Evaluation
Complex Programming to Meet Higher Regulatory Demand Behavioral health programs and organizations aim to prevent or control substance abuse, mental health symptoms, disability and death. Over time, as this task has become more complex, programs themselves have necessarily become more complex. Increasingly, behavioral and … Read More
HRSA Service Area Competition Cycles
In case you missed it, three more cycles for the 2020 grant award year remain with the following due dates: September 30, October 21, and November 18. Service Area Competition announcements are funding opportunities for public and private nonprofit community-based and patient-directed organizations that provide … Read More
CMS Announces State Opportunity for Planning Grant Addressing Substance Use
On June 25, CMS released a planning grant open to all states to address treatment access and capacity building for Medicaid providers to deliver SUD recovery services. It leans on states to implement ongoing assessment of SUD treatment needs with a focus on recruitment, training, … Read More
SAMSHA Grantees: Making Use of Technical Assistance Funds
SAMSHA grantees can look forward to accessing technical assistance (TA) funds tied to the award they received for 2018 projects. Previously, TA was offered at the national level with designated TA centers by region and grant type. However, SAMSHA is now offering a different … Read More
Expert Knowledge on Policy and Practice to Improve Access to Opioid Addiction Treatment
The following is in a recent article from Aetna: “Aetna will be the first national payer to waive copays for Narcan for its fully-insured commercial members – a move that will increase access and remove possible financial barriers to the lifesaving drug. In addition, Aetna … Read More